Dermata Therapeutics: Clinical Trials

6 trials sponsored by Dermata Therapeutics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Unknown 1
Phase 31Completed 1

Follow Dermata Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DMT310-009 Topical in the Treatment of Acne Vulgaris
DMT310, Placebo - Acne Vulgaris
Phase 3CompletedDermata Therapeutics5202023-12-082025-08-22
DMT310-005 Topical in the Treatment of Acne Rosacea
Topical Powder, Placebo Topical Powder - Acne Rosacea
Phase 2UnknownDermata Therapeutics1802021-11-152022-12-08
DMT310-003 Topical in the Treatment of Acne Vulgaris
DMT310, Placebo - Acne Vulgaris
Phase 2CompletedDermata Therapeutics1812019-10-102020-07-22
DMT310-001 Topical in the Treatment of Acne Vulgaris
DMT310, Hydrogen Peroxide, Placebo - Acne Vulgaris
Phase 2CompletedDermata Therapeutics1212018-05-222020-07-22
DMT210 Topical Gel in the Treatment of Acne Rosacea
DMT210 Topical Gel 5%, Vehicle Control - Acne Rosacea
Phase 2CompletedDermata Therapeutics1072017-01-012018-04-18
DMT210 Topical Gel in the Treatment of Atopic Dermatitis
DMT210 Topical Gel, Vehicle Control - Atopic Dermatitis
Phase 2CompletedDermata Therapeutics192016-10-012018-04-18

Conditions studied

Acne Vulgaris (3)  ·  Rosacea (2)  ·  Skin Diseases (2)  ·  Dermatitis (1)  ·  Dermatitis, Atopic (1)  ·  Eczema (1)  ·  Hypersensitivity (1)  ·  Immune System Diseases (1)  ·  Skin Diseases, Eczematous (1)  ·  Skin Diseases, Genetic (1)

Interventions

Hydrogen Peroxide (1)  ·  Powders (1)

Countries

United States (6)

Top investigators

Christopher Nardo, PhD (1)